Zhejiang Xinguang Pharmaceutical Co Ltd Total Assets
Zhejiang Xinguang Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) holds total assets worth CN¥893.41 Million CNY (≈ $130.73 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Zhejiang Xinguang Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.
Total Assets of Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
Total assets of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See Zhejiang Xinguang Pharmaceutical Co Ltd (300519) stock price for real-time trading data and today's change.
Zhejiang Xinguang Pharmaceutical Co Ltd - Asset Composition Analysis
Zhejiang Xinguang Pharmaceutical Co Ltd Total Assets Breakdown (December 2024)
Zhejiang Xinguang Pharmaceutical Co Ltd total assets breakdown as of December 2024. Zhejiang Xinguang Pharmaceutical Co Ltd's total assets of CN¥893.41 Million consist of 85.2% current assets and 14.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 55.3% |
| Accounts Receivable | CN¥12.62 Million | 1.4% |
| Inventory | CN¥69.34 Million | 7.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥7.88 Million | 0.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Zhejiang Xinguang Pharmaceutical Co Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Xinguang Pharmaceutical Co Ltd's current assets represent 85.2% of total assets in 2024, an increase from 54.4% in 2011.
- Cash Position: Cash and equivalents constituted 55.3% of total assets in 2024, up from 28.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 8.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 7.6% of total assets.
Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Xinguang Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Zhejiang Xinguang Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.41 | 11.50 | 14.20 |
| Quick Ratio | 12.35 | 10.56 | 13.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥710.41 Million | CN¥688.12 Million | CN¥690.58 Million |
Zhejiang Xinguang Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Xinguang Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.99 |
| Latest Market Cap to Assets Ratio | 0.37 |
| Asset Growth Rate (YoY) | -2.2% |
| Total Assets | CN¥909.78 Million |
| Market Capitalization | $336.91 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Xinguang Pharmaceutical Co Ltd's assets below their book value (0.37x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Xinguang Pharmaceutical Co Ltd's assets decreased by 2.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total assets of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥909.78 Million ≈ $133.13 Million |
-2.22% |
| 2023-12-31 | CN¥930.41 Million ≈ $136.15 Million |
-2.86% |
| 2022-12-31 | CN¥957.76 Million ≈ $140.15 Million |
+2.72% |
| 2021-12-31 | CN¥932.40 Million ≈ $136.44 Million |
+4.67% |
| 2020-12-31 | CN¥890.79 Million ≈ $130.35 Million |
+3.44% |
| 2019-12-31 | CN¥861.13 Million ≈ $126.01 Million |
+4.70% |
| 2018-12-31 | CN¥822.50 Million ≈ $120.36 Million |
+6.12% |
| 2017-12-31 | CN¥775.05 Million ≈ $113.41 Million |
+10.57% |
| 2016-12-31 | CN¥700.95 Million ≈ $102.57 Million |
+93.17% |
| 2015-12-31 | CN¥362.87 Million ≈ $53.10 Million |
+19.72% |
| 2014-12-31 | CN¥303.10 Million ≈ $44.35 Million |
+23.08% |
| 2013-12-31 | CN¥246.26 Million ≈ $36.04 Million |
+13.25% |
| 2012-12-31 | CN¥217.44 Million ≈ $31.82 Million |
-0.87% |
| 2011-12-31 | CN¥219.35 Million ≈ $32.10 Million |
-- |
About Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more